{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:12:42Z","timestamp":1787940762296,"version":"build-2784847793"},"reference-count":68,"publisher":"Oncology Nursing Society (ONS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2007,6,1]]},"DOI":"10.1188\/07.cjon.433-439","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T10:43:20Z","timestamp":1187865800000},"page":"433-439","source":"Crossref","is-referenced-by-count":14,"title":["Aromatase Inhibitors and Musculoskeletal Pain in Patients With Breast Cancer"],"prefix":"10.1188","volume":"11","author":[{"given":"Loren","family":"Winters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karleen","family":"Habin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Gallagher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1302","published-online":{"date-parts":[[2007,7,10]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Anderson, W.F., Chatterjee, N., Ershler, W.B., & Brawley, O.W. (2002). Estrogen receptor breast cancer phenotypes in the Surveillance Epidemiology and End Results Database. Breast Cancer Research and Treatment<\/i>, 76<\/b>, 27-36.","DOI":"10.1023\/A:1020299707510"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Avis, N.E., Stellato, R., Crawford, S., Bromberger, J., Ganz, P., Cain, V., et al. (2001). Is there a menopausal syndrome? Menopausal status and symptoms across racial\/ethnic groups. Social Science and Medicine<\/i>, 52<\/b>, 345-356.","DOI":"10.1016\/S0277-9536(00)00147-7"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Barnabei, V.M., Cochrane, B.B., Aragaki, A.K., Nygaard, I., Williams, R.S., McGovern, P.G., et al. (2005). Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstetrics and Gynecology<\/i>, 105<\/b>, 1063-1073.","DOI":"10.1097\/01.AOG.0000158120.47542.18"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Baum, M. (2005). Adjuvant endocrine therapy in postmenopausal women with early stage breast cancer: Where are we now? European Journal of Cancer<\/i>, 41<\/b>, 1667-1677.","DOI":"10.1016\/j.ejca.2005.05.006"},{"key":"E00005","unstructured":"Baum, M., Buzdar, A., Cuzick, J., Forbes, J., Houghton, J., Howell, A., et al. (2003). Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early stage breast cancer: Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analysis. Cancer<\/i>, 98<\/b>, 1802-1810."},{"key":"E00006","unstructured":"Baum, M., Budzar, A.U., Cuzick, J., Forbes, J., Houghton, J.H., Klijn, J.G., et al. (2002). Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomized trial. Lancet<\/i>, 359<\/b>, 2131-2139."},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Berman, B.M., Lao, L., Langenberg, P., Lee, W.L., Gilpin, A.M., & Hochberg, M.C. (2004). Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: A randomized, controlled trial. Annals of Internal Medicine<\/i>, 141<\/b>, 901-910.","DOI":"10.7326\/0003-4819-141-12-200412210-00006"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Berry, J. (2005). Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer. Clinical Therapeutics<\/i>, 27<\/b>, 1671-1684.","DOI":"10.1016\/j.clinthera.2005.11.013"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Braham, R., Dawson, B., & Goodman, C. (2003). The effect of glucosamine supplementation on people experiencing regular knee pain. British Journal of Sports Medicine<\/i>, 37<\/b>(1), 45-49.","DOI":"10.1136\/bjsm.37.1.45"},{"key":"E00010","unstructured":"Brandt, K. (2005). Osteoarthritis. In A. Kasper, D. Fauci, E. Longo, S. Braunwald, S. Hauser, & J. Jameson (Eds.), Harrison's principles of internal medicine<\/i> (16th ed., vol. 2, pp. 2036-2045). New York: McGraw Hill."},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Breast International Group (BIG) 1-98 Collaborative Group. (2005). A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. New England Journal of Medicine<\/i>, 353<\/b>, 2747-2757.","DOI":"10.1056\/NEJMoa052258"},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Buettner, C., Kroenke, C.H., Phillips, R.S., Davis, R.B., Eisenberg, D.M., & Holmes, M.D. (2006). Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Research and Treatment<\/i>, 100<\/b>, 219-227.","DOI":"10.1007\/s10549-006-9239-3"},{"key":"E00013","unstructured":"Burstein, H.J. (in press). Aromatase inhibitor-associated arthralgia syndrome. Breast.<\/i> Retrieved May 23, 2007, from http:\/\/dx.doi.org\/10.1016\/j.breast.2007.01.011<\/a>"},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Buzdar, A.U. (2003). Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer. Oncologist<\/i>, 8<\/b>, 335-341.","DOI":"10.1634\/theoncologist.8-4-335"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Buzdar, A.U., Robertson, J.F., Eiermann, W., & Nabholtz, J.M. (2002). An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane. Cancer<\/i>, 95<\/b>, 2006-2016.","DOI":"10.1002\/cncr.10908"},{"key":"E00016","unstructured":"Casper, R. (2006). Clinical manifestations and diagnosis of menopause. Up to Date.<\/i> Retrieved May 20, 2007, from http:\/\/patients.uptodate.com\/topic.asp?file=r_endo_f\/14535&title=Menopause<\/a>"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Cauley, J.A., Robbins, J., Chen, Z., Cummings, S.R., Jackson, R.D., LaCroix, A.Z., et al. (2003). Effects of estrogen plus progestin on risk of fracture and bone mineral density. JAMA<\/i>, 290<\/b>, 1729-1738.","DOI":"10.1001\/jama.290.13.1729"},{"key":"E00018","unstructured":"Centers for Disease Control and Prevention. (2005). Arthritis. Retrieved June 30, 2006, from http:\/\/www.cdc.gov\/arthritis\/arthritis\/index.htm<\/a>"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Clegg, D.O., Reda, D.J., Harris, C.L., Klein, M.A., O'Dell, J.R., Hooper, M.M., et al. (2006). Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. New England Journal of Medicine<\/i>, 354<\/b>, 795-808.","DOI":"10.1056\/NEJMoa052771"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Coombes, R.C., Hall, E., Gibson, L.J., Paridaens, R., Jassem, J., Delozier, T., et al. (2004). A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine<\/i>, 350<\/b>, 1081-1092.","DOI":"10.1056\/NEJMoa040331"},{"key":"E00021","unstructured":"Cush, J., & Lipsky, P. (2006). Algorithm for diagnosis of musculoskeletal complaints. In A. Kasper, D. Fauci, E. Longo, S. Braunwald, S. Hauser, & J. Jameson (Eds.), Harrison's principles of internal medicine<\/i> (16th ed., vol. 2, p. 2030). New York: McGraw Hill."},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Cutolo, M., Capellino, S., Sulli, A., Seriolli, B., Secchi, M.E., Villaggio, B., et al. (2006). Estrogens and autoimmune diseases. Annals of the New York Academy of Sciences<\/i>, 1089<\/b>, 538-547.","DOI":"10.1196\/annals.1386.043"},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Lane, N.E., & Thompson, J.M. (1997). Management of osteoarthritis in the primary care setting: An evidence-based approach to treatment. American Journal of Medicine<\/i>103<\/b>(Suppl. 6A), 25S-30S.","DOI":"10.1016\/S0002-9343(97)90005-X"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Le Bail, J., Liagre, B., Vergne, P., Bertin, P., Beneytout, J., & Habrioux, G. (2001). Aromatase in synovial cells from postmenopausal women. Steroids<\/i>, 66<\/b>, 749-757.","DOI":"10.1016\/S0039-128X(01)00104-0"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Lengacher, C.A., Bennett, M.P., Kip, K.E., Gonzalez, L., Jacobsen, P., & Cox, C.E. (2006). Relief of symptoms, side effects, and psychological distress through the use of complementary and alternative medicine in women with breast cancer. Oncology Nursing Forum<\/i>, 33<\/b>, 97-104.","DOI":"10.1188\/06.ONF.97-104"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Dennison, E., Mohamed, M.A., & Cooper, C. (2006). Epidemiology of osteoporosis. Rheumatic Diseases Clinics of North America<\/i>, 32<\/b>, 617-629.","DOI":"10.1016\/j.rdc.2006.08.003"},{"key":"E00027","unstructured":"Donnellan, P.P., Douglas, S.L., Cameron, D.A., & Leonard, R.C. (2001). Aromatase inhibitors and arthralgia [Correspondence]. Journal of Clinical Oncology<\/i>, 19<\/b>, 2767."},{"key":"E00028","doi-asserted-by":"crossref","unstructured":"Fallowfield, L. (2005). Acceptance of adjuvant therapy and quality of life issues. Breast<\/i>, 14<\/b>, 612-616.","DOI":"10.1016\/j.breast.2005.08.012"},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"Fallowfield, L., Cella, D., Cuzick, J., Francis, S., Locker, G., & Howell, A. (2004). Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. Journal of Clinical Oncology<\/i>, 22<\/b>, 4261-4271.","DOI":"10.1200\/JCO.2004.08.029"},{"key":"E00030","doi-asserted-by":"crossref","unstructured":"Fellowes, D., Fallowfield, L.J., Saunders, C.M., & Houghton, J. (2001). Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for \u2018well tolerated\u2019 treatments? Breast Cancer Research and Treatment<\/i>, 66<\/b>(1), 73-81.","DOI":"10.1023\/A:1010684903199"},{"key":"E00031","doi-asserted-by":"crossref","unstructured":"Felson, D., & Cummings, S.R. (2005). Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis and Rheumatism<\/i>, 52<\/b>, 2594-2598.","DOI":"10.1002\/art.21364"},{"key":"E00032","unstructured":"Fox, D. (2005). Etiology and pathogenesis of rheumatoid arthritis. In W. Koopman & L. Moreland (Eds.), Arthritis and allied conditions<\/i> (pp. 1089-1092). Philadelphia: Lippincott Williams and Wilkins."},{"key":"E00033","doi-asserted-by":"crossref","unstructured":"Fransen, M., McConnell, S., & Bell, M. (2003). Exercise for osteoarthritis of the hip or knee. Cochrane Database for Systematic Review<\/i>, CD004286.","DOI":"10.1016\/S0031-9406(05)60174-5"},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"Given, B., Given, C., McCorkle, R., Kozachik, S., Cimprich, B., Hossein-Rahbar, M., et al. (2002). Pain and fatigue management: Results of a nursing randomized clinical trial. Oncology Nursing Forum<\/i>, 29<\/b>, 949-956.","DOI":"10.1188\/02.ONF.949-956"},{"key":"E00035","doi-asserted-by":"crossref","unstructured":"Goss, P.E., Ingle, J.N., Martino, S., Robert, N.J., Muss, H.B., Piccart, M.J., et al. (2003). A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early stage breast cancer. New England Journal of Medicine<\/i>, 349<\/b>, 1793-1802.","DOI":"10.1056\/NEJMoa032312"},{"key":"E00036","doi-asserted-by":"crossref","unstructured":"Goss, P.E., Ingle, J.N., Martino, S., Robert, N.J., Muss, H.B., Piccart, M.J., et al. (2005). Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17. Journal of the National Cancer Institute<\/i>, 97<\/b>, 1262-1271.","DOI":"10.1093\/jnci\/dji250"},{"key":"E00037","unstructured":"Harnish, D.C. (2006). Estrogen receptor ligands in the control of pathogenic inflammation. Current Opinion in Investigational Drugs<\/i>, 7<\/b>, 997-1001."},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Hawker, G.A., Wright, J.G., Coyte, P.C., Williams, I., Harvey, B., Glazier, R., et al. (2000). Differences between men and women in the rate of use of hip and knee arthroplasty. New England Journal of Medicine<\/i>, 342<\/b>, 1016-1022.","DOI":"10.1056\/NEJM200004063421405"},{"key":"E00039","doi-asserted-by":"crossref","unstructured":"Jakesz, R., Jonat, W., Gnant, M., Mittlboeck, M., Greil, R., Tausch, C., et al. (2005). Switching of postmenopausal women with endocrine-responsive early stage breast cancer to anastrozole after 2 years' adjuvant tamoxifen: Combined results of ABCSG Trial 8 and ARNO 95 Trial. Lancet<\/i>, 366<\/b>, 455-462.","DOI":"10.1016\/S0140-6736(05)67059-6"},{"key":"E00040","doi-asserted-by":"crossref","unstructured":"Kemmler, W., Lauber, D., Weineck, J., Hensen, J., Kalender, W., & Engelke, K. (2004). Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women: Results of the Erlangen Fitness Osteoporosis Prevention Study (EFOPS). Archives of Internal Medicine<\/i>, 164<\/b>, 1084-1091.","DOI":"10.1001\/archinte.164.10.1084"},{"key":"E00041","doi-asserted-by":"crossref","unstructured":"Lengacher, C.A., Bennett, M.P., Kip, K.E., Keller, R., LaVance, M.S., Smith, L.S., et al. (2002). Frequency of use of complementary and alternative medicine in women with breast cancer. Oncology Nursing Forum<\/i>, 29<\/b>, 1445-1452.","DOI":"10.1188\/02.ONF.1445-1452"},{"key":"E00042","doi-asserted-by":"crossref","unstructured":"Lonning, P.E. (1996). Aromatase inhibition for breast cancer treatment. Acta Oncologia<\/i>, 35<\/b>(Suppl. 5), 38-43.","DOI":"10.3109\/02841869609083966"},{"key":"E00043","doi-asserted-by":"crossref","unstructured":"Markes, M., Brockow, T., & Resch, K.L. (2006). Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database for Systematic Review<\/i>, CD005001.","DOI":"10.1002\/14651858.CD005001.pub2"},{"key":"E00044","unstructured":"Martin, V. (2004). Arthralgias and myalgias. In C. Yarbo, M. Frogge, & M. Goodman (Eds.), Cancer symptom management<\/i> (3rd ed., pp. 17-27). Sudbury, MA: Jones and Bartlett."},{"key":"E00045","doi-asserted-by":"crossref","unstructured":"McNeely, M.L., Campbell, K.L., Rowe, B.H., Klassen, T.P., Mackey, J.R., & Courneya, K.S. (2006). Effects of exercise on breast cancer patients and survivors: A systematic review and meta-analysis. Canadian Medical Association Journal<\/i>, 175<\/b>(1), 34-41.","DOI":"10.1503\/cmaj.051073"},{"key":"E00046","unstructured":"National Cancer Institute. (1999). Common toxicity criteria for adverse events v2.0.<\/i> Retrieved August 30, 2006, from http:\/\/ctep.cancer.gov\/forms\/CTCAEv3.pdf<\/a>"},{"key":"E00047","unstructured":"National Comprehensive Cancer Network. (2007). NCCN clinical practice guidelines in oncology: Breast cancer<\/i> (version 2.2007). Retrieved May 23, 2007, from http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/breast.pdf<\/a>"},{"key":"E00048","doi-asserted-by":"crossref","unstructured":"Nevitt, M.C., Cummings, S.R., Lane, N.E., Hochberg, M.C., Scott, J.C., Pressman, A.R., et al. (1996). Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women: Study of Osteoporotic Fractures Research Group. Archives of Internal Medicine<\/i>, 156<\/b>, 2073-2080.","DOI":"10.1001\/archinte.1996.00440170081009"},{"key":"E00049","unstructured":"Perez, E.A., & Weilbaecher, K. (2006). Aromatase inhibitors and bone loss. Oncology<\/i>, 20<\/b>, 1029-1039."},{"key":"E00050","doi-asserted-by":"crossref","unstructured":"Quandt, S.A., Chen, H., Grzywacz, J.G., Bell, R.A., Lang, W., & Arcury, T.A. (2005). Use of complementary and alternative medicine by persons with arthritis: Results of the National Health Interview Survey. Arthritis and Rheumatism<\/i>, 53<\/b>, 748-755.","DOI":"10.1002\/art.21443"},{"key":"E00051","doi-asserted-by":"crossref","unstructured":"Rowinsky, E.K., Chaudhry, V., Forestiere, A., Sartorius, S.E., Ettinger, D.S., Grochow, L.B., et al. (1993). Phase I pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: Neuromuscular toxicity is dose limiting. Journal of Clinical Oncology<\/i>, 11<\/b>, 2010-2020.","DOI":"10.1200\/JCO.1993.11.10.2010"},{"key":"E00052","doi-asserted-by":"crossref","unstructured":"Scharla, S., Oertel, H., Helsberg, K., Kessler, F., Langer, F., & Nickelsen, T. (2006). Skeletal pain in postmenopausal women with osteoporosis: Prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration. Current Medical Research and Opinion<\/i>, 22<\/b>, 2393-2402.","DOI":"10.1185\/030079906X154097"},{"key":"E00053","doi-asserted-by":"crossref","unstructured":"Simpson, E.R. (2003). Sources of estrogen and their importance. Journal of Steroid Biochemistry and Molecular Biology<\/i>, 86<\/b>, 225-230.","DOI":"10.1016\/S0960-0760(03)00360-1"},{"key":"E00054","doi-asserted-by":"crossref","unstructured":"Siris, E.S., Miller, P.D., Barret-Connor, E., Faulkner, K.G., Wehren, L.E., Abbott, T.A., et al. (2001). Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: Results from the National Osteoporosis Risk Assessment. JAMA<\/i>, 286<\/b>, 2815-2822.","DOI":"10.1001\/jama.286.22.2815"},{"key":"E00055","doi-asserted-by":"crossref","unstructured":"Soeken, K.L. (2004). Selected CAM therapies for arthritis-related pain: The evidence from systematic reviews. Clinical Journal of Pain<\/i>, 20<\/b>(1), 13-18.","DOI":"10.1097\/00002508-200401000-00004"},{"key":"E00056","unstructured":"Spector, T.D., Hart, D.J., Brown, P., Almeyda, J., Dacre, J.E., Doyle, D.V., et al. (1991). Frequency of osteoarthritis in hysterectomized women. Journal of Rheumatology<\/i>, 18<\/b>, 1877-1883."},{"key":"E00057","doi-asserted-by":"crossref","unstructured":"Spector, T.D., Nandra, D., Hart, D.J., & Doyle, D.V. (1997). Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford Study. Annals of the Rheumatic Diseases<\/i>, 56<\/b>, 432-434.","DOI":"10.1136\/ard.56.7.432"},{"key":"E00058","unstructured":"Sueblinvong, T., Taechakraichana, N., & Phupong, V. (2001). Prevalence of climacteric symptoms according to years after menopause. Journal of the Medical Association of Thailand<\/i>, 84<\/b>, 1681-1691."},{"key":"E00059","doi-asserted-by":"crossref","unstructured":"Thomas, R. (2003). Examining quality of life issues in relation to endocrine therapy for breast cancer. American Journal of Clinical Oncology<\/i>, 26<\/b>(4, Suppl. 1), S40-S44.","DOI":"10.1097\/00000421-200308001-00007"},{"key":"E00060","doi-asserted-by":"crossref","unstructured":"Tobias, J.S. (2004). Recent advances in endocrine therapy for postmenopausal women with early breast cancer: Implications for treatment and prevention. Annals of Oncology<\/i>, 15<\/b>, 1738-1747.","DOI":"10.1093\/annonc\/mdh485"},{"key":"E00061","doi-asserted-by":"crossref","unstructured":"Tutuncu, Z., & Kavanaugh, A. (2007). Rheumatic disease in the elderly: Rheumatoid arthritis. Rheumatic Diseases Clinics of North America<\/i>, 33<\/b>, 57-70.","DOI":"10.1016\/j.rdc.2006.12.006"},{"key":"E00062","doi-asserted-by":"crossref","unstructured":"Vas, J., Mendez, C., Perea-Milla, E., Vega, E., Panadero, M.D., Leon, J.M., et al. (2004). Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: Randomized controlled trial. BMJ<\/i>, 329<\/b>, 1216.","DOI":"10.1136\/bmj.38238.601447.3A"},{"key":"E00063","doi-asserted-by":"crossref","unstructured":"Whelan, T.J., Goss, P.E., Ingle, J.N., Pater, J.L., Tu, D., Pritchard, K., et al. (2005). Assessment of quality of life in MA 17: A randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. Journal of Clinical Oncology<\/i>, 23<\/b>, 6931-6940.","DOI":"10.1200\/JCO.2005.11.181"},{"key":"E00064","unstructured":"Wilkes, G.M., & Barton-Burke, M. (2005). Biologic response modifier therapy. In Oncology nursing drug handbook<\/i> (p. 358). Sudbury, MA: Jones and Bartlett."},{"key":"E00065","doi-asserted-by":"crossref","unstructured":"Winer, E.P., Hudis, C., Burstein, H.J., Wolff, A.C., Pritchard, K.I., Ingle, J.N., et al. (2005). American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004. Journal of Clinical Oncology<\/i>, 23<\/b>, 619-629.","DOI":"10.1200\/JCO.2005.09.121"},{"key":"E00066","unstructured":"Wysowski, D., & Chang, J. (2005). Alendronate and risedronate: Reports of severe bone, joint, and muscle pain. Archives of Internal Medicine<\/i>, 165<\/b>, 346-347."},{"key":"E00067","doi-asserted-by":"crossref","unstructured":"Xu, J., Bartoces, M., Neale, A.V., Dailey, R.K., Northrup, J., & Schwartz, K.L. (2005). Natural history of menopause symptoms in primary care patients: A MetroNet Study. Journal of the American Board of Family Practice<\/i>, 18<\/b>, 374-382.","DOI":"10.3122\/jabfm.18.5.374"},{"key":"E00068","doi-asserted-by":"crossref","unstructured":"Zubieta, J.K., Bueller, J.A., Jackson, L.R., Scott, D.J., Xu, Y., Koeppe, R.A., et al. (2005). Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. Journal of Neuroscience<\/i>, 25<\/b>, 7754-7762.","DOI":"10.1523\/JNEUROSCI.0439-05.2005"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/37K05X01G17J1L52.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:10Z","timestamp":1763754670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/11\/3\/aromatase-inhibitors-and-musculoskeletal-pain-patients-breast"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6,1]]}},"alternative-id":["37K05X01G17J1L52"],"URL":"https:\/\/doi.org\/10.1188\/07.cjon.433-439","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}